Treatment of hypertension in patients undergoing coronary artery by-pass grafting

Current Opinion in Pharmacology
Lukasz J Krzych

Abstract

Hypertension occurs in up to 80% of patients scheduled to coronary artery by-pass grafting (CABG). In hemodynamically stable patients all anti-hypertensive drugs should be continued till a day of surgery. For vast majority of patients there is no need to use blood pressure lowering agents during CABG, however it is necessary to maintain blood pressure level and avoid extreme blood pressure variations. Upon CABG hypotensive therapy should be modified to the needs of the individual patient and should be monitored individually. Treatment of hypertension ought to be started with caution with lowest possible dosage. Aggressive therapy is strongly discouraged to avoid hemodynamic collapse. Beta-blockers should be administered to all CABG patients unless contraindicated.

References

Feb 1, 1993·The Thoracic and Cardiovascular Surgeon·U NyströmK Rådegran
Sep 27, 2003·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·P L van HaelstW H van Gilst
Jan 18, 2005·Journal of the American College of Cardiology·Karen OkrainecMark J Eisenberg
Apr 8, 2006·The Journal of Cardiovascular Nursing·Kathryn M Ganske
Feb 20, 2007·The Annals of Thoracic Surgery·Abhinav GoyalUNKNOWN PREVENT IV Investigators
Mar 14, 2007·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·C Michael WhiteCraig I Coleman
Apr 3, 2007·Heart Rhythm : the Official Journal of the Heart Rhythm Society·William L BakerCraig I Coleman
Sep 14, 2007·Circulation·Jeremiah R BrownUNKNOWN Northern New England Cardiovascular Disease Study Group
Dec 7, 2007·International Journal of Cardiology·Jacqueline Müller-NordhornStefan N Willich
Dec 12, 2007·Circulation·Jean L RouleauUNKNOWN IMAGINE (Ischemia Management with Accupril post-bypass Graft via Inhibition of the coNverting Enzyme) Investigators
Jul 23, 2008·Perspectives in Vascular Surgery and Endovascular Therapy·Kimon Bekelis, Nicos Labropoulos
Sep 23, 2008·The Annals of Thoracic Surgery·Umberto BenedettoRiccardo Sinatra
Jul 7, 2009·Journal of Cardiothoracic and Vascular Anesthesia·Lukasz J KrzychAndrzej Bochenek
Aug 18, 2009·Journal of the American College of Cardiology·Antonio MiceliMassimo Caputo
Sep 2, 2009·Journal of Cardiovascular Pharmacology and Therapeutics·Mehran ShahzamaniPeyman Nejatbakhsh Azadani
Oct 20, 2009·Journal of Hypertension·Giuseppe ManciaUNKNOWN European Society of Hypertension
Nov 12, 2009·Cardiovascular Therapeutics·Javad KojuriMahammad Bagher Sharifkazemi
Mar 13, 2010·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Georgia RagiaVangelis G Manolopoulos
Mar 30, 2010·General Thoracic and Cardiovascular Surgery·Kiyoshi TamuraNaoto Miyagi
Apr 20, 2010·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Michele D PierriLucia Torracca
Sep 28, 2010·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·UNKNOWN Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for CardDavid Taggart
Sep 30, 2010·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·A John CammUNKNOWN ESC Committee for Practice Guidelines
Dec 21, 2010·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Marijana TadicNevenka Zivkovic

❮ Previous
Next ❯

Citations

Oct 27, 2020·Physiotherapy Research International : the Journal for Researchers and Clinicians in Physical Therapy·Breno Caldas RibeiroRodrigo Santiago Barbosa Rocha

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Related Papers

The Journal of Thoracic and Cardiovascular Surgery
Anita Y M ChanAlberta Provincial Program for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators
The Annals of Thoracic Surgery
Mark Stafford-Smith
© 2022 Meta ULC. All rights reserved